PRELUDE CAPITAL MANAGEMENT, LLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 145 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$631,000
-49.2%
40,029
-49.8%
0.02%
-56.8%
Q2 2021$1,241,000
-2.7%
79,784
-10.2%
0.04%
+12.1%
Q1 2021$1,276,000
+127500.0%
88,826
+88726.0%
0.03%
Q3 2020$1,000
-98.9%
100
-95.5%
0.00%
-100.0%
Q3 2018$92,000
-58.0%
2,228
-83.2%
0.01%
-75.0%
Q3 2017$219,00013,2250.02%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$3,280,00010.95%
M28 Capital Management LP 439,300$1,440,9041.37%
Redmile Group, LLC 6,242,756$20,476,2400.84%
MAVERICK CAPITAL LTD 6,291,013$20,634,5230.49%
Baupost Group 8,123,616$26,6450.44%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 52,000$1710.25%
WASATCH ADVISORS LP 8,391,014$27,522,5250.18%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$1,722,0000.17%
STALEY CAPITAL ADVISERS INC 450,000$1,4760.09%
Virtus ETF Advisers LLC 36,100$118,4080.06%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders